AtaiBeckley Inc. ATAI

Latest FY: 2025 Healthcare Biotechnology
Market Price $7.34
Market Cap $2.70B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑1,227.6% YoY
$4.09M
3-Yr CAGR: 159.9%
Net Income ↑87.2% YoY
-$100.00K
Net Margin: -2.4%
Free Cash Flow ↓-25.6% YoY
-$103.58M
FCF Yield: -3.83%
EPS (Diluted) ↓-212.9% YoY
$-2.91
Basic: $-2.91
Return on Equity Efficiency
-0.0%
ROA: -0.0%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ATAI)

All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
  • FY 2023: Revenue YoY (+34.8%) is identical to Gross Profit YoY (+34.8%). Verify the underlying Revenue and Gross Profit values for FY 2023 and FY 2022.
  • FY 2024: Revenue YoY (-1.9%) is identical to Gross Profit YoY (-1.9%). Verify the underlying Revenue and Gross Profit values for FY 2024 and FY 2023.
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2021 0.00%
FY 2022 $0.2M $0.2M $-152.4M 0.00% $-104.5M $-105.5M
FY 2023 $0.3M +34.8% $0.3M $-40.2M +73.6% 0.00% $-84.1M $-84.7M +19.7%
FY 2024 $0.3M -1.9% $0.3M $-0.8M +98.1% $-0.93 0.00% $-82.4M $-82.4M +2.7%
FY 2025 $4.1M +1,227.6% $2.9M $-0.1M +87.2% $-2.91 -212.9% 0.00% $-102.7M $-103.6M -25.6%
$

Valuation

Market Price $7.34
Market Cap $2.70B
Enterprise Value $2.62B
P/E Ratio N/A
P/B Ratio 12.18
FCF Yield -3.83%
Dividend Yield 0.00%
Shares Outstanding 368,166,674
%

Profitability & Margins

Gross Margin 71.58%
Operating Margin -15,751.06%
Net Margin -2.45%
Return on Equity (ROE) -0.05%
Return on Assets (ROA) -0.03%
Asset Turnover 0.01x
Revenue 3-Yr CAGR 159.87%
🛡️

Financial Health & Liquidity

Current Ratio 11.74
Cash Ratio 3.63
Debt / Equity 0.009
Debt / Assets 0.007
Cash & Equivalents $85.30M
Total Debt $2.07M
Book Value / Share $0.60
💧

Cash Flow Efficiency

Operating Cash Flow -$102.67M
Capital Expenditures (CapEx) $901.00K
Free Cash Flow -$103.58M
OCF / Revenue -2,511.01%
FCF / Revenue -2,533.04%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-2.91
EPS (Basic) $-2.91
Dividends / Share N/A
Book Value / Share $0.60
EPS YoY Growth -212.90%
🏛️

Balance Sheet (FY 2025)

Total Assets $292.72M
Total Liabilities $70.72M
Stockholders' Equity $221.87M
Current Assets $275.68M
Current Liabilities $23.48M